5th Street Advisors’s AbbVie ABBV Stock Holding History

5th Street Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302K	Hold	1,200	–	–	0.11%	44
2026 Q1	$261K	Sell	1,200 -34	-3%	-$7.54K	0.11%	44
2025 Q4	$282K	Buy	+1,234	New	+$281K	0.13%	38
2025 Q2	–	Sell	-1,400	Closed	-$293K	–	35
2025 Q1	$293K	Buy	+1,400	New	+$272K	0.14%	38
2024 Q4	–	Sell	-1,400	Closed	-$276K	–	30
2024 Q3	$276K	Buy	+1,400	New	+$261K	0.13%	33

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

5th Street Advisors's ABBV Position: Q2 2026 in Review

5th Street Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 1,200 shares worth $302K. The position accounts for 0.11% of the portfolio, ranked #44.

5th Street Advisors first reported a position in ABBV in Q3 2024 and has held it in 5 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

5th Street Advisors held 1,200 shares of AbbVie worth $302K as of Q2 2026.
5th Street Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.11% of 5th Street Advisors's portfolio in Q2 2026, its #44 holding.
5th Street Advisors first reported a position in AbbVie in Q3 2024 and has held it in 5 quarters since.
4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 5th Street Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.